Mandate

Vinge advises Opus Group in conjunction with issuance of bonds

Opus Group AB (publ) (”Opus”) has issued a so called senior unsecured bond in the amount of MSEK 500 MSEK with a term of four years on the Nordic market.

The bond, with a framework amount of MSEK 800, is subject to a variable interest rate of STIBOR 3m + 375 interest points and has a final maturity date in May 2022. The proceeds from the bond issue will primarily be used for refinancing Opus’ outstanding bond in the amount of MSEK 500 with a final maturity date on 20 November 2018 (ISIN: SE0005556834). Opus will apply for listing of the bond on Nasdaq Stockholm.

Vinge’s team consisted of partner Anders Strid together with, among others, associates Yohanna Öhrnegård and Lina André.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025